Organization

Antoni van Leeuwenhoek

1 abstract

1 poster

Poster

Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab and vinorelbine in HER2-amplified metastatic breast cancer patients (MBC) who had progressed on anti-HER2 antibody drug conjugates (ADCs)

Abstract

AUTOANTIBODY-POSITIVITY BEFORE TREATMENT IS ASSOCIATED WITH IMMUNE-RELATED ADVERSE EVENTS IN MELANOMA PATIENTS TREATED WITH ANTI-PD-1

Org: Leiden University Medical Center, Netherlands Cancer Institute, Sanquin Diagnostic Services, Amsterdam, Netherlands, Oncode Institute, Antoni van Leeuwenhoek,